Literature DB >> 3030274

Competitive inhibition of human skin collagenase by N-benzyloxycarbonyl-L-prolyl-L-alanyl-3-amino-2-oxopropyl-L-leucyl-L- alanylglycine ethyl ester.

D A Wallace, S R Bates, B Walker, G Kay, J White, D J Guthrie, N L Blumson, D T Elmore.   

Abstract

A 'ketomethylene' peptide, N-benzyloxycarbonyl-L-prolyl-L-alanyl-3-amino- 2-oxopropyl-L-leucyl-L-alanylglycine ethyl ester, was synthesized and shown to be a fairly potent competitive inhibitor of human skin collagenase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3030274      PMCID: PMC1147360          DOI: 10.1042/bj2390797

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Mercaptoimidazolylpropionic acid hydrobromide. Inhibition of tadpole collagenase and related properties.

Authors:  J A Yankeelov; H A Parish; A F Spatola
Journal:  J Med Chem       Date:  1978-07       Impact factor: 7.446

2.  Identification and partial characterization of an inhibitor of collagenase from rabbit bone.

Authors:  A Sellers; J J Reynolds
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857

3.  The release of collagenase as an inactive proenzyme by bone explants in culture.

Authors:  G Vaes
Journal:  Biochem J       Date:  1972-01       Impact factor: 3.857

Review 4.  The determination of collagen and elastin.

Authors:  D S Jackson; E G Cleary
Journal:  Methods Biochem Anal       Date:  1967

5.  Metal binding peptide inhibitors of vertebrate collagenase.

Authors:  R D Gray; H H Saneii; A F Spatola
Journal:  Biochem Biophys Res Commun       Date:  1981-08-31       Impact factor: 3.575

6.  The collagen substrate specificity of human skin fibroblast collagenase.

Authors:  H G Welgus; J J Jeffrey; A Z Eisen
Journal:  J Biol Chem       Date:  1981-09-25       Impact factor: 5.157

7.  A new class of angiotensin-converting enzyme inhibitors.

Authors:  A A Patchett; E Harris; E W Tristram; M J Wyvratt; M T Wu; D Taub; E R Peterson; T J Ikeler; J ten Broeke; L G Payne; D L Ondeyka; E D Thorsett; W J Greenlee; N S Lohr; R D Hoffsommer; H Joshua; W V Ruyle; J W Rothrock; S D Aster; A L Maycock; F M Robinson; R Hirschmann; C S Sweet; E H Ulm; D M Gross; T C Vassil; C A Stone
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

8.  A recording viscometer for assaying mammalian collagenase.

Authors:  H W Macartney; S R Bates; N L Blumson; D Nelson; D Jamison; D T Elmore
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

9.  Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein.

Authors:  C Kettner; E Shaw
Journal:  Biochemistry       Date:  1978-10-31       Impact factor: 3.162

10.  Inhibition of angiotensin converting enzyme by phosphoramidates and polyphosphates.

Authors:  R E Galardy
Journal:  Biochemistry       Date:  1982-11-09       Impact factor: 3.162

View more
  1 in total

Review 1.  Matrix metalloproteinases. Novel targets for directed cancer therapy.

Authors:  A E Yu; R E Hewitt; E W Connor; W G Stetler-Stevenson
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.